Corporate News
Director/PDMR Shareholding
30 January 2025
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 97,500 ordinary shares of 4 pence each in the Company ("Ordinary Shares") on 29 January 2025, at a price of 3.668 pence each.
A summary of Carolyn Rand's resultant holdings is below:
Director | Board Position | Number of Ordinary Shares acquired | Total beneficial holding of Ordinary Shares following this acquisition | |
Number of Ordinary Shares | Approximate % of Company's issued share capital | |||
Carolyn Rand | Non-Executive Chair | 97,500 | 97,500 | 0.04% |
Contacts:
Cambridge Nutritional Sciences plc | ||||
Carolyn Rand, Non-Executive Chair | ||||
James Cooper, Interim Chief Executive | ||||
Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |||
Geoff Nash / Edward Whiley (Corporate Finance) | ||||
Nigel Birks / Harriet Ward (ECM) |
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Carolyn Rand | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Chair | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a) | Name | Cambridge Nutritional Sciences plc | ||||
b) | LEI | 2138007U9P4BTZTYIR92 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 4 pence each
ISIN: GB00B1VCP282 | ||||
b) | Nature of the transaction | Ordinary Shares purchased | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
-Aggregated volume
- Price
| See above | ||||
e) | Date of the transaction | 29.01.2025 | ||||
f) | Place of the transaction | London Stock Exchange |
Latest Share Price
Investor News
-
30 January 2025
Director/PDMR Shareholding -
21 January 2025
Omega Diagnostics court summons